Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
After finishing at $178.08 in the prior trading day, Charles River Laboratories International Inc (NYSE: CRL) closed at $173.91, down -2.34%. In other words, the price has decreased by -$2.34 from its previous closing price. On the day, 1.21 million shares were traded. CRL stock price reached its highest trading level at $182.0 during the session, while it also had its lowest trading level at $173.81.
Ratios:
Our goal is to gain a better understanding of CRL by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 42.25 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.87. For the most recent quarter (mrq), Quick Ratio is recorded 1.14 and its Current Ratio is at 1.48. In the meantime, Its Debt-to-Equity ratio is 0.73 whereas as Long-Term Debt/Eq ratio is at 0.73.
On November 07, 2024, CLSA Upgraded its rating to Hold which previously was Underperform but kept the price unchanged to $205.
On October 23, 2024, CLSA started tracking the stock assigning a Underperform rating and target price of $167.CLSA initiated its Underperform rating on October 23, 2024, with a $167 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 07 ’24 when WALLMAN RICHARD F sold 6,621 shares for $216.12 per share. The transaction valued at 1,430,918 led to the insider holds 12,386 shares of the business.
WALLMAN RICHARD F sold 1,000 shares of CRL for $216,500 on Nov 07 ’24. The Director now owns 0 shares after completing the transaction at $216.50 per share. On Nov 07 ’24, another insider, WALLMAN RICHARD F, who serves as the Director of the company, bought 12,161 shares for $216.01 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRL now has a Market Capitalization of 8893096960 and an Enterprise Value of 11491054592. As of this moment, Charles’s Price-to-Earnings (P/E) ratio for their current fiscal year is 21.47, and their Forward P/E ratio for the next fiscal year is 17.48. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 7.48. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.19 while its Price-to-Book (P/B) ratio in mrq is 2.35. Its current Enterprise Value per Revenue stands at 2.83 whereas that against EBITDA is 12.112.
Stock Price History:
The Beta on a monthly basis for CRL is 1.39, which has changed by -0.13599533 over the last 52 weeks, in comparison to a change of 0.22212577 over the same period for the S&P500. Over the past 52 weeks, CRL has reached a high of $275.00, while it has fallen to a 52-week low of $175.61. The 50-Day Moving Average of the stock is -9.76%, while the 200-Day Moving Average is calculated to be -16.32%.
Shares Statistics:
The stock has traded on average 694.00K shares per day over the past 3-months and 712800 shares per day over the last 10 days, according to various share statistics. A total of 51.13M shares are outstanding, with a floating share count of 50.59M. Insiders hold about 1.08% of the company’s shares, while institutions hold 102.95% stake in the company. Shares short for CRL as of 1735603200 were 2257761 with a Short Ratio of 3.25, compared to 1732838400 on 2179281. Therefore, it implies a Short% of Shares Outstanding of 2257761 and a Short% of Float of 5.7299999999999995.
